COMP <GO>
EVI vs EVH // ENTERPRISE SCALE & MARKET CAP
EVI Industries Inc. (NYSE) VS. Evolent Health Inc (Class A) (NYSE) • 15-METRIC TALLY: EVI 9
— EVH 2
▲ ENTERPRISE SCALE & MARKET CAP LEADER: EVH
LAST: $21.72 (+1.26%) • MKT CAP: $279.7M
market-cap
$279.7M
LAST: $4.25 (-1.85%) • MKT CAP: $480.5M
market-cap
$480.5M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EVI VS. EVH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EVI | EVH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 30.40% | 21.30% | +9.10 | EVI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.40% | -26.30% | +31.70 | EVI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.9x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 5.86% | 8.08% | -2.22 | EVH | /fcf-yield <GO> |
| Operating Margin | 3.50% | -21.90% | +25.40 | EVI | /operating-margins <GO> |
| Net Profit Margin | 1.90% | -30.90% | +32.80 | EVI | /net-margins <GO> |
| Revenue Growth (YoY) | 10.30% | -26.60% | +36.90 | EVI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.64% | 0.00% | +1.64 | EVI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.73 | 0.20 | +2.53 | EVI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 4/9 | +5.00 | EVI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 68.6 | 49.2 | +19.44 | EVI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.7x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $279.7M | $480.5M | -$200.8M | EVH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EVI REV | EVH REV | EVI GROSS % | EVH GROSS % | EVI FCF | EVH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $389.8M | $1.88B | 30.4% | 21.3% | $16.4M | $38.8M |
| FY 2024 | $353.6M | $2.55B | 29.8% | 14.4% | $32.7M | $18.8M |
| FY 2023 | $354.2M | $1.96B | — | — | $940.0K | $142.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EVI // BETA —
EVH // BETA —